Westlake Therapeutics
PrivateLast Round
Series B
Jun 18, 2026
Total Funding Raised
$74.48M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Westlake Therapeutics is a biotechnology company that develops engineered red blood cell therapies for the treatment of cancer, autoimmune diseases, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Westlake Therapeutics Comparables
Compare Westlake Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coastar Therapeutics | 83% | |
| Synth-Med Biotechnology Inc. | 83% | |
| Scarlet Therapeutics | 78% |
Westlake Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 18, 2026 | ||||
| Series A Extension | Jun 25, 2022 | ||||
| Series A | Jul 15, 2021 | ||||
| Pre Seed | Jan 25, 2021 | ||||
| Pre Seed | Jun 2, 2020 |
Westlake Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tasly Holding Group | Pre Seed |
| Eight Roads Ventures | Pre Seed, Series A |
| 西湖科创投 | Series A Extension, Pre Seed |
| Shaanxi Investment Group | Pre Seed |
| Westlake District's Science and Technology Direct Investment Fund | Pre Seed |
| HongShan Capital Group (HSG) | Series B, Pre Seed, Series A |
| Shenzhen Yifeng Investment Management Enterprise | Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 50% MoM.
- Jun 18, 2026
$15M round led by HongShan Capital Group.
Westlake Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Westlake Therapeutics's valuation, stock price, and market status.
Is Westlake Therapeutics a public or private company?
Westlake Therapeutics is a private company.
What is the current stock price of Westlake Therapeutics?
Westlake Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Westlake Therapeutics worth (valuation)?
Valuation information for Westlake Therapeutics is not publicly available.
Can I buy Westlake Therapeutics stock?
Westlake Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Westlake Therapeutics's last funding round?
Westlake Therapeutics's most recent funding round was Series A on January 23, 2021.
Who are the main investors in Westlake Therapeutics?
Key investors in Westlake Therapeutics include Westlake District's Science and Technology Direct Investment Fund.
Will Westlake Therapeutics IPO soon?
No public IPO plans have been announced for Westlake Therapeutics.
How can I track Westlake Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Westlake Therapeutics's secondary market activity and sign up for updates.